Prosecution Insights
Last updated: May 29, 2026

Examiner: KUCHARCZK, JED A

Tech Center 1600 • Art Units: 1623 1626

This examiner grants 80% of resolved cases

Performance Statistics

80.2%
Allow Rate
+20.2% vs TC avg
117
Total Applications
+15.6%
Interview Lift
1005
Avg Prosecution Days
Based on 91 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
19.0%
§102 Novelty
45.9%
§103 Obviousness
9.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19220457 METHODS OF DISPERSING ARIPIPRAZOLE INJECTABLE PREPARATIONS Non-Final OA Otsuka Pharmaceutical Co., Ltd.
17996310 HERBICIDAL COMPOUNDS Non-Final OA SYNGENTA CROP PROTECTION AG
17721813 COMPOSITIONS AND THEIR USE Non-Final OA SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
18258346 NOVEL NAMPT ENZYME AGONIST AND PREPARATION AND USE THEREOF Non-Final OA TSINGHUA UNIVERSITY
18020451 Serotonin Receptor Modulators Final Rejection Northeastern University
17628106 Modulators of Excitatory Amino Acid Transporters and Methods Using Same Final Rejection Drexel University
17311624 COMPOSITIONS AND METHODS FOR REGULATING INFLAMMATION Final Rejection University of Virginia Patent Foundation
18574939 CANNABICHROMENE DERIVATIVES AND METHODS FOR MAKING AND USING THE SAME Non-Final OA University of Mississippi
18099319 ORAL CAPSULE AND PREPARATION METHOD THEREFOR Final Rejection BEIGENE SWITZERLAND GMBH
17617531 ORAL CAPSULE AND PREPARATION METHOD THEREFOR Final Rejection BEIGENE SWITZERLAND GMBH
16980773 PHARMACEUTICAL COMPOSITIONS HAVING HIGH DRUG LOADINGS OF MEDIUM CHAIN TRIGLYCERIDES AND METHODS RELATED THERETO Non-Final OA Cerecin Inc.
17620427 FORMULATIONS OF RBP4 INHIBITORS AND METHODS OF USE Non-Final OA Belite Bio, LLC
18548109 SN-38 DERIVATIVE, NANO-PARTICLES CONTAINING SAID DERIVATIVE, MEDICINE, AND METHOD FOR PRODUCING SAID NANO-PARTICLES Non-Final OA JAPAN SCIENCE AND TECHNOLOGY AGENCY
18249647 ORAL CANNABINOID FORMULATION COMPRISING MEDIUM CHAIN TRIGLYCERIDES AND TOCOPHERYL PHOSPHATES Non-Final OA AVECHO BIOTECHNOLOGY LIMITED
17764922 MEDICINAL COGNITIVE TREATMENTS Non-Final OA ACTINOGEN MEDICAL LIMITED
17281210 SYNERGISTIC PESTICIDAL COMPOSITIONS FOR DELIVERY OF PESTICIDAL ACTIVE INGREDIENTS AND METHODS THEREFOR Non-Final OA 0903608 B.C. Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month